Cargando…

Metformin Treatment Attenuates Brain Inflammation and Rescues PACAP/VIP Neuropeptide Alterations in Mice Fed a High-Fat Diet

High-fat diet (HFD)-induced comorbid cognitive and behavioural impairments are thought to be the result of persistent low-grade neuroinflammation. Metformin, a first-line medication for the treatment of type-2 diabetes, seems to ameliorate these comorbidities, but the underlying mechanism(s) are not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mandwie, Mawj, Karunia, Jocelyn, Niaz, Aram, Keay, Kevin A., Musumeci, Giuseppe, Rennie, Claire, McGrath, Kristine, Al-Badri, Ghaith, Castorina, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706124/ https://www.ncbi.nlm.nih.gov/pubmed/34948457 http://dx.doi.org/10.3390/ijms222413660

Ejemplares similares

PACAP and VIP Modulate LPS-Induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells
por: Karunia, Jocelyn, et al.
Publicado: (2021)

Altered Hippocampal and Striatal Expression of Endothelial Markers and VIP/PACAP Neuropeptides in a Mouse Model of Systemic Lupus Erythematosus
por: Lee, Jayden, et al.
Publicado: (2023)

Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury
por: Broome, Sarah Thomas, et al.
Publicado: (2023)

Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System
por: Musumeci, Giuseppe, et al.
Publicado: (2018)

Rapid GFAP and Iba1 expression changes in the female rat brain following spinal cord injury
por: Mandwie, Mawj, et al.
Publicado: (2021)

PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells
por: Broome, Sarah Thomas, et al.
Publicado: (2022)

Potential Crosstalk between the PACAP/VIP Neuropeptide System and Endoplasmic Reticulum Stress—Relevance to Multiple Sclerosis Pathophysiology
por: Withana, Minduli, et al.
Publicado: (2023)

PACAP and VIP Neuropeptides’ and Receptors’ Effects on Appetite, Satiety and Metabolism
por: Vu, John P., et al.
Publicado: (2023)

Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP
por: Temerozo, Jairo R., et al.
Publicado: (2013)

Molecular Basis of Class B GPCR Selectivity for the Neuropeptides PACAP and VIP
por: Liao, Chenyi, et al.
Publicado: (2021)

Messenger RNA Gene Expression Screening of VIP and PACAP Neuropeptides and Their Endogenous Receptors in Ruminants
por: Hawley, Emma, et al.
Publicado: (2022)

Signal Transduction by VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2022)

Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis
por: Jansen, Margo I., et al.
Publicado: (2022)

PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP
por: Bensalma, Souheyla, et al.
Publicado: (2019)

Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
por: Langer, Ingrid, et al.
Publicado: (2021)

Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
por: Lu, Jessica, et al.
Publicado: (2022)

Female reproductive functions of the neuropeptide PACAP
por: Koppan, Miklos, et al.
Publicado: (2022)

Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP
por: Schytz, Henrik Winther, et al.
Publicado: (2010)

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study
por: Deligianni, Christina, et al.
Publicado: (2023)

Adipose Tissue Expression of PACAP, VIP, and Their Receptors in Response to Cold Stress
por: Cline, Daemon L., et al.
Publicado: (2018)

Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells
por: Thomas Broome, Sarah, et al.
Publicado: (2021)

Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
por: Tan, Yossan-Var, et al.
Publicado: (2011)

Agnathan VIP, PACAP and Their Receptors: Ancestral Origins of Today's Highly Diversified Forms
por: Ng, Stephanie Y. L., et al.
Publicado: (2012)

From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment
por: Tanaka, Masaru, et al.
Publicado: (2023)

Distinct VIP and PACAP Functions in the Distal Nerve Stump During Peripheral Nerve Regeneration
por: Woodley, Patricia K., et al.
Publicado: (2019)

The neuropeptide PACAP alleviates T. gondii infection-induced neuroinflammation and neuronal impairment
por: Figueiredo, Caio Andreeta, et al.
Publicado: (2022)

Research on the mechanism of prednisone in the treatment of ITP via VIP/PACAP-mediated intestinal immune dysfunction
por: Yan, Xiang, et al.
Publicado: (2023)

Roles of Neuropeptides, VIP and AVP, in the Mammalian Central Circadian Clock
por: Ono, Daisuke, et al.
Publicado: (2021)

PACAP for Retinal Health: Model for Cellular Aging and Rescue
por: Pöstyéni, Etelka, et al.
Publicado: (2021)

PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression
por: Maugeri, Grazia, et al.
Publicado: (2016)

Expression and significance of TIMP-3, PACAP and VIP in vaginal wall tissues of patients with stress urinary incontinence
por: Fan, Bo, et al.
Publicado: (2017)

Corrigendum: Roles of Neuropeptides, VIP and AVP, in the Mammalian Central Circadian Clock
por: Ono, Daisuke, et al.
Publicado: (2021)

Ameliorative Effects of PACAP against Cartilage Degeneration. Morphological, Immunohistochemical and Biochemical Evidence from in Vivo and in Vitro Models of Rat Osteoarthritis
por: Giunta, Salvatore, et al.
Publicado: (2015)

Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018)

PACAP and Other Neuropeptide Targets Link Chronic Migraine and Opioid-induced Hyperalgesia in Mouse Models*
por: Anapindi, Krishna D.B., et al.
Publicado: (2019)

Neuropeptide immunofluorescence in human nasal mucosa: assessment of the technique for vasoactive intestinal peptide (VIP)
por: de Mendonça, Jeferson Cedaro, et al.
Publicado: (2015)

Interferon-γ Produced by Microglia and the Neuropeptide PACAP Have Opposite Effects on the Viability of Neural Progenitor Cells
por: Mäkelä, Johanna, et al.
Publicado: (2010)

Effects of PACAP on Schwann Cells: Focus on Nerve Injury
por: Maugeri, Grazia, et al.
Publicado: (2020)

Immunoreactivity of NOS, CGRP, PACAP, SP and VIP in the trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2 of the cat
por: Christiansen, Tove, et al.
Publicado: (2003)

The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney
por: Horvath, Gabriella, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_17nmacvc2rkvut93pjegck0v81